xtantmedical.com - XTNT Market Value to Book Value Ratio

xtantmedical.com - graphic logo of issuer XTNT

This price chart for Xtant Medical Holdings (XTNT) illustrates the dynamics of a company that mitigates risks through the production of spinal fixation systems and bio-implants for tissue regeneration. Business scaling relies on external agents to reduce personnel costs, with the current metric standing at 0.95. The environmental strategy is based on energy conservation and the safe disposal of waste from sterile production facilities.

xtantmedical.com (XTNT) Market Capitalization to Net Assets: for the period 07/04/2022 - 10/31/2026

Analytical breakdowns and data insights for company Xtant Medical Holdings (XTNT)

- share price and consensus valuation forecast:
Stock Quotes xtantmedical.com|XTNT - Analyst Forecast Prices
- issuer market value details:
Market Value Xtant Medical Inc|XTNT - Company Buyout Price
- book capitalization data:
Net Assets per Single Share Xtant Medical|XTNT - Net Asset Value|Market Capitalization to Book Value Ratio xtantmedical.com|XTNT - Company Assets
- debt level and financial liquidity data:
Total Debt to Capital Xtant Medical Holdings|XTNT - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital xtantmedical.com|XTNT - Company Total Debt Obligations|Debts to Book Capitalization Xtant Medical Inc|XTNT - Company Long-Term Debts|Company Short-Term Debt Xtant Medical|Quick Ratio xtantmedical.com
- earnings and market multiples details:
XTNT - Net Financial Result
Analysis of all company metrics:Xtant Medical Holdings, Inc. - XTNT
Flagship merchandise of Xtant Medical Holdings

Investors must compare the current share price with the actual value of assets to avoid overpaying. The market value to book value multiple reflects the market consensus regarding the ratio of the exchange price to equity. An increase in this ratio signals inflated expectations that ignore fiscal risks. For Xtant Medical (XTNT), such a premium is justified by the creation of unique bioactive materials for bone regeneration. The innovative nature of the products allows the market to value Xtant Medical (XTNT) above its formal balance sheet.

Competitor analysis

BSX (Boston Scientific) - Market Cap to Net Assets Ratio|EW: Market Cap to Book Value Multiple|Market Value to Book Value Ratio ResMed|Insulet Corp (PODD) - Market Capitalization to Book Value|Market Value to Book Value Ratio Zimmer Biomet Holdings, Inc. (ZBH)|COO: Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio ALGN (Align Technology, Inc.)|globusmedical.com (GMED) - Market-to-Book Ratio|TransMedics Group - Market Capitalization to Book Value Ratio|Alphatec Holdings (ATEC) - Market Cap to Net Assets Ratio|AORT: Market Capitalization to Book Value Ratio|ENOV - Market Capitalization to Book Value|IART (Integra LifeSciences) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio establishmentlabs.com|Market Value to Book Value Ratio Beta Bionics (BBNX)|Market Value to Book Value Ratio IRMD (IRADIMED Corp)|Market Capitalization to Book Value Ratio EMBC (Embecta Inc.)|Market Capitalization to Book Value Tandem Corp (TNDM)|AXGN: Market Cap to Net Assets Ratio|Market Capitalization to Net Assets SIBN|OFIX: Market Capitalization to Book Value Ratio|Market-to-Book Ratio Bioventus Inc (BVS)|KIDS (OrthoPediatrics Corp) - Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio TMCI (Treace Corp)|Market Cap to Net Assets Ratio SRTA (Strata Critical Medical Inc)|CARL (carlsmed.com) - Market Value to Book Value|Market Value to Book Value Ratio RxSight RXST|CLPT - Market Cap to Net Assets Ratio|Stereotaxis Corp - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Neuronetics, Inc|SGHT: Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio OBIO|ANIK (Anika Therapeutics Inc.) - Market Capitalization to Book Value Ratio|InspireMD Inc (NSPR) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio ZJYL|Market Cap to Net Assets Ratio vivani.com VANI|Market Capitalization to Book Value Ratio NMTC (NeuroOne Medical Technologies)|Market Capitalization to Book Value Ratio Modular Medical Inc MODD|MYO - Market Value to Book Value Ratio|COCH: Market Value to Book Value Ratio|VVOS (Vivos Therapeutics, Inc) - Market Cap to Net Assets Ratio|enVVeno Corp - Market Value to Book Value|SINT (Sintx Technologies Inc) - Market Capitalization to Book Value Ratio|Market-to-Book Ratio tenonmed.com TNON|Market Value to Book Value Ratio Lifeward (LFWD)|autonomix.com (AMIX) - Market Value to Equity Ratio|INVO Bioscience, Inc. - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio Bone Biologics Inc BBLG|Axonics, Inc. - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value biolase.com BIOL|dynatronics.com (DYNT) - Market Value to Book Value Ratio|Market Capitalization to Net Assets FNA (Paragon 28)|Market Value to Book Value Ratio INVO Bioscience Inc.